Cleared Special

K130090 - STA COMPACT MAX

K130090 is an FDA 510(k) clearance for STA COMPACT MAX, manufactured by Diagnostica Stago, Incorporated. The device is a Class 2 Hematology device with product code JPA cleared through the Special 510(k) pathway after a 29-day FDA review.

K130090 · Diagnostica Stago, Incorporated · Hematology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2013
Decision
29d
Days
Class 2
Risk

K130090 is an FDA 510(k) clearance for the STA COMPACT MAX. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Diagnostica Stago, Incorporated (Rome, IT). The FDA issued a Cleared decision on February 12, 2013 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K130090

510(k) Number K130090 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 14, 2013
Decision Date February 12, 2013
Days to Decision 29 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 113d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 181
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K130090.
Sysmex Automated Blood Coagulation Analyzer CS-5100
K150678 · Siemens Healthcare Diagnostic Products GmbH · Jan 2016
STA R MAX
K151867 · Diagnostica Stago S.A.S · Aug 2015
CORA (Coagulation Resonance Analysis) System
K150041 · Coramed Technologies, LLC · Jun 2015
EX-TEM. FIB-TEM, AND AP-TEM FOR ROTEM DELTA THROMBOELASTOMETRY SYSTEM
K101533 · Tem Innovations GmbH · Aug 2011
ROTEM DELTA THROMBOELASTOMETRY SYSTEM
K083842 · Pentapharm GmbH · Mar 2010
STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZER
K093167 · Diagnostica Stago, Inc. · Dec 2009
K130090 · STA COMPACT MAX
Download PDF FDA Summary Diagnostica Stago, In…